• Pharmacists Center

    The Pharmacists Center features helpful resources, links, and tools supporting healthcare provider and patient education as well as useful information for practicing oncology pharmacists. Pharmacists Center

  • Nurses Center

    The Nurses Center features helpful resources, links, and tools supporting nurse and patient education as well as the practice of oncology nursing. Nurses Center

  • Fellows Center

    The Fellows Center features helpful resources, links, and tools supporting oncology fellows' education and current clinical practice. Fellows Center

References

  1. Rubin LL, de Sauvage FJ. Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov. 2006;5:1026-1033.

  2. Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001;15:3059-3087.

  3. Evangelista M, Tian H, de Sauvage FJ. The Hedgehog signaling pathway in cancer. Clin Cancer Res. 2006;12:5924-5928.

  4. Yauch RL, Gould SE, Scales SJ, et al. A paracrine requirement for hedgehog signalling in cancer. Nature. 2008;455:406-410.

  5. Scales SJ, de Sauvage FJ. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci. 2009;30:303-312.

  6. Theunissen J-W, de Sauvage FJ. Paracrine Hedgehog signaling in cancer. Cancer Res. 2009;69:6007-6010.

  7. Williams JA, Guicherit OM, Zaharian BI, et al. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci U S A. 2003;100:4616-4621.

  8. Romer JT, Kimura H, Magdaleno S, et al. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1+/-p53-/- mice. Cancer Cell. 2004;6:229-240.

  9. Robarge KD, Brunton SA, Castanedo GM, et al. GDC-0449-a potent inhibitor of the hedgehog pathway. Bioorg Med Chem Lett. 2009;19:5576-5581.